Skip to main content
Erschienen in: Journal of Gastroenterology 9/2011

01.09.2011 | Original Article—Alimentary Tract

Effect of repetitive transcranial magnetic stimulation on rectal function and emotion in humans

verfasst von: Yuuichi Aizawa, Joe Morishita, Michiko Kano, Takayuki Mori, Shin-Ichi Izumi, Kenichiro Tsutsui, Toshio Iijima, Motoyori Kanazawa, Shin Fukudo

Erschienen in: Journal of Gastroenterology | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

A previous brain imaging study demonstrated activation of the right dorsolateral prefrontal cortex (DLPFC) during visceral nociception, and this activation was associated with anxiety. We hypothesized that functional modulation of the right DLPFC by repetitive transcranial magnetic stimulation (rTMS) can reveal the actual role of right DLPFC in brain–gut interactions in humans.

Methods

Subjects were 11 healthy males aged 23.5 ± 1.4 (mean ± SE) years. Viscerosensory evoked potential (VEP) with sham (0 mA) or actual (30 mA) electrical stimulation (ES) of the rectum was taken after sham, low frequency rTMS at 0.1 Hz, and high frequency rTMS at 10 Hz to the right DLPFC. Rectal tone was measured with a rectal barostat. Visceral perception and emotion were analyzed using an ordinate scale, rectal barostat, and VEP.

Key results

Low frequency rTMS significantly reduced anxiety evoked by ES at 30 mA (p < 0.05). High frequency rTMS–30 mA ES significantly produced more phasic volume events than sham rTMS–30 mA ES (p < 0.05).

Conclusions and inferences

We successfully modulated the gastrointestinal function of healthy individuals through rTMS to the right DLPFC. Thus, rTMS to the DLPFC appears to modulate the affective, but not direct, component of visceral perception and motility of the rectum.
Literatur
1.
Zurück zum Zitat Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.PubMedCrossRef Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.PubMedCrossRef
2.
Zurück zum Zitat Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–60.PubMedCrossRef Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–60.PubMedCrossRef
3.
Zurück zum Zitat Amouretti M, Le Pen C, Gaudin AF, Bommelaer G, Frexinos J, Ruszniewski P, et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol. 2006;30:241–6.PubMedCrossRef Amouretti M, Le Pen C, Gaudin AF, Bommelaer G, Frexinos J, Ruszniewski P, et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol. 2006;30:241–6.PubMedCrossRef
4.
Zurück zum Zitat Park JM, Choi MG, Kim YS, Choi CH, Choi SC, Hong SJ, et al. Quality of life of patients with irritable bowel syndrome in Korea. Qual Life Res. 2009;18:435–46.PubMedCrossRef Park JM, Choi MG, Kim YS, Choi CH, Choi SC, Hong SJ, et al. Quality of life of patients with irritable bowel syndrome in Korea. Qual Life Res. 2009;18:435–46.PubMedCrossRef
5.
Zurück zum Zitat Gralnek IM, Hays RD, Kilbourne AM, Chang L, Mayer EA. Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol. 2004;38:782–9.PubMedCrossRef Gralnek IM, Hays RD, Kilbourne AM, Chang L, Mayer EA. Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol. 2004;38:782–9.PubMedCrossRef
6.
Zurück zum Zitat Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.PubMedCrossRef Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.PubMedCrossRef
7.
Zurück zum Zitat Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97:1910–5.PubMed Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97:1910–5.PubMed
8.
Zurück zum Zitat Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther. 2005;21:663–76.PubMedCrossRef Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther. 2005;21:663–76.PubMedCrossRef
9.
Zurück zum Zitat Kanazawa M, Endo Y, Whitehead WE, Kano M, Hongo M, Fukudo S. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004;49:1046–53.PubMedCrossRef Kanazawa M, Endo Y, Whitehead WE, Kano M, Hongo M, Fukudo S. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004;49:1046–53.PubMedCrossRef
10.
Zurück zum Zitat Locke GR 3rd, Yawn BP, Wollan PC, Melton LJ 3rd, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004;19:1025–31.PubMedCrossRef Locke GR 3rd, Yawn BP, Wollan PC, Melton LJ 3rd, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004;19:1025–31.PubMedCrossRef
11.
Zurück zum Zitat Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain–gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol. 1993;17:133–41.PubMedCrossRef Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain–gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol. 1993;17:133–41.PubMedCrossRef
12.
Zurück zum Zitat Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280:G519–24.PubMed Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280:G519–24.PubMed
13.
Zurück zum Zitat Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med. 1987;151:373–85.PubMedCrossRef Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med. 1987;151:373–85.PubMedCrossRef
14.
Zurück zum Zitat Fukudo S, Kanazawa M, Kano M, Sagami Y, Endo Y, Utsumi A, et al. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome. J Gastroenterol. 2002;37:145–50.PubMedCrossRef Fukudo S, Kanazawa M, Kano M, Sagami Y, Endo Y, Utsumi A, et al. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome. J Gastroenterol. 2002;37:145–50.PubMedCrossRef
15.
Zurück zum Zitat Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33:825–30.PubMedCrossRef Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33:825–30.PubMedCrossRef
16.
Zurück zum Zitat Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130:1435–46.PubMedCrossRef Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130:1435–46.PubMedCrossRef
17.
Zurück zum Zitat Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology. 1997;112:1714–43.PubMedCrossRef Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology. 1997;112:1714–43.PubMedCrossRef
18.
Zurück zum Zitat Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The working team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997;42:223–41.PubMedCrossRef Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The working team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997;42:223–41.PubMedCrossRef
19.
Zurück zum Zitat Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002;122:1771–7.PubMedCrossRef Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002;122:1771–7.PubMedCrossRef
20.
Zurück zum Zitat Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004;53:958–64.PubMedCrossRef Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004;53:958–64.PubMedCrossRef
21.
Zurück zum Zitat Kanazawa M, Endo M, Yamaguchi K, Hamaguchi T, Whitehead WE, Itoh M, et al. Classical conditioned response of rectosigmoid motility and regional cerebral activity in humans. Neurogastroenterol Motil. 2005;17:705–13.PubMedCrossRef Kanazawa M, Endo M, Yamaguchi K, Hamaguchi T, Whitehead WE, Itoh M, et al. Classical conditioned response of rectosigmoid motility and regional cerebral activity in humans. Neurogastroenterol Motil. 2005;17:705–13.PubMedCrossRef
22.
Zurück zum Zitat Dsmdt JE. Somatosensory CEP in man. In: Cobb WA, editor. Handbook of electrosensory and neurophysiology. Amsterdam: Elsevier; 1971. p. 55–82. Dsmdt JE. Somatosensory CEP in man. In: Cobb WA, editor. Handbook of electrosensory and neurophysiology. Amsterdam: Elsevier; 1971. p. 55–82.
23.
Zurück zum Zitat Hollerbach S, Kamath MV, Chen Y, Fitzpatrick D, Upton AR, Tougas G. The magnitude of the central response to esophageal electrical stimulation is intensity dependent. Gastroenterology. 1997;112:1137–46.PubMedCrossRef Hollerbach S, Kamath MV, Chen Y, Fitzpatrick D, Upton AR, Tougas G. The magnitude of the central response to esophageal electrical stimulation is intensity dependent. Gastroenterology. 1997;112:1137–46.PubMedCrossRef
24.
Zurück zum Zitat Hobson AR, Sarkar S, Furlong PL, Thompson DG, Aziz Q. A cortical evoked potential study of afferents mediating human esophageal sensation. Am J Physiol Gastrointest Liver Physiol. 2000;279:G139–47.PubMed Hobson AR, Sarkar S, Furlong PL, Thompson DG, Aziz Q. A cortical evoked potential study of afferents mediating human esophageal sensation. Am J Physiol Gastrointest Liver Physiol. 2000;279:G139–47.PubMed
25.
Zurück zum Zitat Kanazawa M, Nomura T, Fukudo S, Hongo M. Abnormal visceral perception in patients with functional dyspepsia: use of cerebral potentials evoked by electrical stimulation of the oesophagus. Neurogastroenterol Motil. 2000;12:87–94.PubMedCrossRef Kanazawa M, Nomura T, Fukudo S, Hongo M. Abnormal visceral perception in patients with functional dyspepsia: use of cerebral potentials evoked by electrical stimulation of the oesophagus. Neurogastroenterol Motil. 2000;12:87–94.PubMedCrossRef
26.
Zurück zum Zitat Fukudo S, Kotake C, Kanazawa M, Sagami Y, Nomura T, Hongo M. Exaggerated viscerosensory evoked potentials in irritable bowel syndrome (abstract). Gastroenterology. 2001;120:A4032. Fukudo S, Kotake C, Kanazawa M, Sagami Y, Nomura T, Hongo M. Exaggerated viscerosensory evoked potentials in irritable bowel syndrome (abstract). Gastroenterology. 2001;120:A4032.
27.
Zurück zum Zitat Bromm B, Lorenz J. Neurophysiological evaluation of pain. Electroencephalogr Clin Neurophysiol. 1998;107:227–53.PubMedCrossRef Bromm B, Lorenz J. Neurophysiological evaluation of pain. Electroencephalogr Clin Neurophysiol. 1998;107:227–53.PubMedCrossRef
28.
Zurück zum Zitat Kanazawa M, Fukudo S, Nomura T, Hongo M. Electrophysiological correlates of personality influences in visceral perception. JAMA. 2001;286:1974–5.PubMedCrossRef Kanazawa M, Fukudo S, Nomura T, Hongo M. Electrophysiological correlates of personality influences in visceral perception. JAMA. 2001;286:1974–5.PubMedCrossRef
29.
Zurück zum Zitat Watanabe S, Hattori T, Kanazawa M, Kano M, Fukudo S. Role of histaminergic neurons in hypnotic modulation of brain processing of visceral perception. Neurogastroenterol Motil. 2007;19:831–8.PubMedCrossRef Watanabe S, Hattori T, Kanazawa M, Kano M, Fukudo S. Role of histaminergic neurons in hypnotic modulation of brain processing of visceral perception. Neurogastroenterol Motil. 2007;19:831–8.PubMedCrossRef
30.
Zurück zum Zitat Barker AT. The history and basic principles of magnetic nerve stimulation. Electroencephalogr Clin Neurophysiol Suppl. 1999;51:3–21.PubMed Barker AT. The history and basic principles of magnetic nerve stimulation. Electroencephalogr Clin Neurophysiol Suppl. 1999;51:3–21.PubMed
31.
Zurück zum Zitat Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–7.PubMedCrossRef Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–7.PubMedCrossRef
32.
Zurück zum Zitat Epstein CM, Schwartzberg DG, Davey KR, Sudderth DB. Localizing the site of magnetic brain stimulation in humans. Neurology. 1990;40:666–70.PubMed Epstein CM, Schwartzberg DG, Davey KR, Sudderth DB. Localizing the site of magnetic brain stimulation in humans. Neurology. 1990;40:666–70.PubMed
33.
Zurück zum Zitat Paus T, Barrett J. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression. J Psychiatry Neurosci. 2004;29:268–79.PubMed Paus T, Barrett J. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression. J Psychiatry Neurosci. 2004;29:268–79.PubMed
34.
Zurück zum Zitat Fitzgerald PB, Brown T, Marston NAU, Daskalakis ZJ, Kularni J. A double-blind placebo controlled trial of transcranial magnetic stimulation in the treatment of depression. Arch Gen Pschiatry. 2003;60:1002–8.CrossRef Fitzgerald PB, Brown T, Marston NAU, Daskalakis ZJ, Kularni J. A double-blind placebo controlled trial of transcranial magnetic stimulation in the treatment of depression. Arch Gen Pschiatry. 2003;60:1002–8.CrossRef
35.
Zurück zum Zitat Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry. 2006;163:88–94.PubMedCrossRef Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry. 2006;163:88–94.PubMedCrossRef
36.
Zurück zum Zitat Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;47:314–24.PubMedCrossRef Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;47:314–24.PubMedCrossRef
37.
Zurück zum Zitat Isenberg K, Downs D, Pierce K, Svarakic D, Garcia K, Jarvis M, et al. Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. Ann Clin Psychiatry. 2005;17:153–9.PubMedCrossRef Isenberg K, Downs D, Pierce K, Svarakic D, Garcia K, Jarvis M, et al. Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. Ann Clin Psychiatry. 2005;17:153–9.PubMedCrossRef
38.
Zurück zum Zitat Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry. 2006;67:1870–6.PubMedCrossRef Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry. 2006;67:1870–6.PubMedCrossRef
39.
Zurück zum Zitat O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–16.PubMedCrossRef O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–16.PubMedCrossRef
40.
Zurück zum Zitat Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–7.PubMedCrossRef Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–7.PubMedCrossRef
41.
Zurück zum Zitat Terui T, Watanabe S, Kanazawa M, Hamaguchi T, Mine H, Yanai K, et al. Differential modulation of the regional brain by hypnotic suggestion between patients with irritable bowel syndrome, healthy subjects. Gastroenterology. 2007;132:A134. Terui T, Watanabe S, Kanazawa M, Hamaguchi T, Mine H, Yanai K, et al. Differential modulation of the regional brain by hypnotic suggestion between patients with irritable bowel syndrome, healthy subjects. Gastroenterology. 2007;132:A134.
42.
Zurück zum Zitat Hamaguchi T, Kano M, Rikimaru H, Kanazawa M, Itoh M, Yanai K, et al. Brain activity during distention of the descending colon in humans. Neurogastroenterol Motil. 2004;16:299–309.PubMedCrossRef Hamaguchi T, Kano M, Rikimaru H, Kanazawa M, Itoh M, Yanai K, et al. Brain activity during distention of the descending colon in humans. Neurogastroenterol Motil. 2004;16:299–309.PubMedCrossRef
43.
Zurück zum Zitat Kanazawa M, Endo M, Yamaguchi K, Hamaguchi T, Whitehead WE, Itoh M, et al. Classical conditioned response of rectosigmoid motility and regional cerebral activity in humans. Neurogastroenterol Motil. 2005;17:705–13.PubMedCrossRef Kanazawa M, Endo M, Yamaguchi K, Hamaguchi T, Whitehead WE, Itoh M, et al. Classical conditioned response of rectosigmoid motility and regional cerebral activity in humans. Neurogastroenterol Motil. 2005;17:705–13.PubMedCrossRef
44.
Zurück zum Zitat Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers; 1988. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers; 1988.
45.
Zurück zum Zitat Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998;42:845–9.PubMedCrossRef Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998;42:845–9.PubMedCrossRef
46.
Zurück zum Zitat Sloots CE, Felt-Bersma RJ, Meuwissen SG, Kuipers EJ. Influence of gender, parity, and caloric load on gastrorectal response in healthy subjects: a barostat study. Dig Dis Sci. 2003;48:516–21.PubMedCrossRef Sloots CE, Felt-Bersma RJ, Meuwissen SG, Kuipers EJ. Influence of gender, parity, and caloric load on gastrorectal response in healthy subjects: a barostat study. Dig Dis Sci. 2003;48:516–21.PubMedCrossRef
47.
Zurück zum Zitat Bell AM, Pemberton JH, Hanson RB, Zinsmeister AR. Variations in muscle tone of the human rectum: recordings with an electromechanical barostat. Am J Physiol. 1991;260:G17–25.PubMed Bell AM, Pemberton JH, Hanson RB, Zinsmeister AR. Variations in muscle tone of the human rectum: recordings with an electromechanical barostat. Am J Physiol. 1991;260:G17–25.PubMed
48.
Zurück zum Zitat Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997;42:223–41.PubMedCrossRef Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997;42:223–41.PubMedCrossRef
49.
Zurück zum Zitat Von der Ohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994;6:213–22. Von der Ohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994;6:213–22.
50.
Zurück zum Zitat Jasper HH. Formal discussion: dendrites. Electroencephalogr Clin Neurophysiol. 1958;10:42–50. Jasper HH. Formal discussion: dendrites. Electroencephalogr Clin Neurophysiol. 1958;10:42–50.
51.
Zurück zum Zitat Aziz Q, Furlong PL, Barlow J, Hobson A, Alani S, Bancewicz J, et al. Topographic mapping of cortical potentials evoked by distension of the human proximal and distal oesophagus. Electroencephalogr Clin Neurophysiol. 1995;96:219–28.PubMedCrossRef Aziz Q, Furlong PL, Barlow J, Hobson A, Alani S, Bancewicz J, et al. Topographic mapping of cortical potentials evoked by distension of the human proximal and distal oesophagus. Electroencephalogr Clin Neurophysiol. 1995;96:219–28.PubMedCrossRef
52.
Zurück zum Zitat Hamdy S, Rothwell JC, Aziz Q, Singh KD, Thompson DG. Long-term reorganization of human motor cortex driven by short-term sensory stimulation. Nat Neurosci. 1998;1:64–8.PubMedCrossRef Hamdy S, Rothwell JC, Aziz Q, Singh KD, Thompson DG. Long-term reorganization of human motor cortex driven by short-term sensory stimulation. Nat Neurosci. 1998;1:64–8.PubMedCrossRef
53.
Zurück zum Zitat Hamdy S, Aziz Q, Rothwell JC, Singh KD, Barlow J, Hughes DG, et al. The cortical topography of human swallowing musculature in health and disease. Nat Med. 1996;2:1217–24.PubMedCrossRef Hamdy S, Aziz Q, Rothwell JC, Singh KD, Barlow J, Hughes DG, et al. The cortical topography of human swallowing musculature in health and disease. Nat Med. 1996;2:1217–24.PubMedCrossRef
54.
Zurück zum Zitat Hoffman RE, Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry. 2002;159:1093–102.PubMedCrossRef Hoffman RE, Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry. 2002;159:1093–102.PubMedCrossRef
55.
Zurück zum Zitat Ogawa A, Ukai S, Shinosaki K, Yamamoto M, Kawaguchi S, Ishii R, et al. Slow repetitive transcranial magnetic stimulation increases somatosensory high-frequency oscillations in humans. Neurosci Lett. 2004;358:193–6.PubMedCrossRef Ogawa A, Ukai S, Shinosaki K, Yamamoto M, Kawaguchi S, Ishii R, et al. Slow repetitive transcranial magnetic stimulation increases somatosensory high-frequency oscillations in humans. Neurosci Lett. 2004;358:193–6.PubMedCrossRef
56.
Zurück zum Zitat Sokhadze E, Baruth J, Tasman A, Mansoor M, Ramaswamy R, Sears L, et al. Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related p measures of novelty processing in autism. Appl Psychophysiol Biofeedback. 2010;35:147–61.PubMedCrossRef Sokhadze E, Baruth J, Tasman A, Mansoor M, Ramaswamy R, Sears L, et al. Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related p measures of novelty processing in autism. Appl Psychophysiol Biofeedback. 2010;35:147–61.PubMedCrossRef
57.
Zurück zum Zitat Kimbrell TA, Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999;46:1603–13.PubMedCrossRef Kimbrell TA, Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999;46:1603–13.PubMedCrossRef
58.
Zurück zum Zitat Speer AM, Kimbrell TA, Wassermann EM D, Repella J, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133–41.PubMedCrossRef Speer AM, Kimbrell TA, Wassermann EM D, Repella J, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133–41.PubMedCrossRef
59.
Zurück zum Zitat Nitschke JB, Sarinopoulos I, Mackiewicz KL, Schaefer HS, Davidson RJ. Functional neuroanatomy of aversion and its anticipation. Neuroimage. 2006;29:106–16.PubMedCrossRef Nitschke JB, Sarinopoulos I, Mackiewicz KL, Schaefer HS, Davidson RJ. Functional neuroanatomy of aversion and its anticipation. Neuroimage. 2006;29:106–16.PubMedCrossRef
60.
Zurück zum Zitat Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry. 1997;42:446–52.PubMedCrossRef Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry. 1997;42:446–52.PubMedCrossRef
61.
Zurück zum Zitat Dalton KM, Kalin NH, Grist TM, Davidson RJ. Neural-cardiac coupling in threat-evoked anxiety. J Cogn Neurosci. 2005;17:969–80.PubMedCrossRef Dalton KM, Kalin NH, Grist TM, Davidson RJ. Neural-cardiac coupling in threat-evoked anxiety. J Cogn Neurosci. 2005;17:969–80.PubMedCrossRef
62.
Zurück zum Zitat Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry. 2008;63:369–76.PubMedCrossRef Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry. 2008;63:369–76.PubMedCrossRef
63.
Zurück zum Zitat Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, et al. Reduction in left prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 1989;46:243–50.PubMed Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, et al. Reduction in left prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 1989;46:243–50.PubMed
64.
Zurück zum Zitat Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia rates assessed by positron emission tomography with (fluorine-18) 2-deoxyglucose in affective illness. J Affect Dis. 1986;10:137–52.PubMedCrossRef Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia rates assessed by positron emission tomography with (fluorine-18) 2-deoxyglucose in affective illness. J Affect Dis. 1986;10:137–52.PubMedCrossRef
65.
Zurück zum Zitat Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–7.PubMedCrossRef Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–7.PubMedCrossRef
66.
Zurück zum Zitat Drevets WC, Videen TO, Preskorn SH, Preskorn SH, Carmichael ST, Raichle ME. A functional neuroanatomical study of unipolar depression. J Neurosci. 1992;12:3628–41.PubMed Drevets WC, Videen TO, Preskorn SH, Preskorn SH, Carmichael ST, Raichle ME. A functional neuroanatomical study of unipolar depression. J Neurosci. 1992;12:3628–41.PubMed
67.
Zurück zum Zitat George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression. 1994;2:59–72.CrossRef George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression. 1994;2:59–72.CrossRef
68.
Zurück zum Zitat Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry. 1990;147:1313–7.PubMed Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry. 1990;147:1313–7.PubMed
69.
Zurück zum Zitat Avery DH, Holtzheimer PE III, Fawaz W, Russo J, Neumaier J, Dunner DL, et al. A controlled study of repetitive transcranial stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59:187–94.PubMedCrossRef Avery DH, Holtzheimer PE III, Fawaz W, Russo J, Neumaier J, Dunner DL, et al. A controlled study of repetitive transcranial stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59:187–94.PubMedCrossRef
70.
Zurück zum Zitat George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6:1853–6.PubMedCrossRef George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6:1853–6.PubMedCrossRef
71.
Zurück zum Zitat George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo controlled crossover trial. Am J Psychiatry. 1997;154:1752–6.PubMed George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo controlled crossover trial. Am J Psychiatry. 1997;154:1752–6.PubMed
72.
Zurück zum Zitat Pascual-Leone A, Rubio B, Pallardó F, Catalá MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996;348:233–7.PubMedCrossRef Pascual-Leone A, Rubio B, Pallardó F, Catalá MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996;348:233–7.PubMedCrossRef
73.
Zurück zum Zitat Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo controlled trial. Psychiatry Res. 2005;137:1–10.PubMedCrossRef Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo controlled trial. Psychiatry Res. 2005;137:1–10.PubMedCrossRef
74.
Zurück zum Zitat Kauffmann CD, Cheema MA, Miller BE. Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depress Anxiety. 2004;19:159–62.CrossRef Kauffmann CD, Cheema MA, Miller BE. Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depress Anxiety. 2004;19:159–62.CrossRef
75.
Zurück zum Zitat Schutter DJ, Laman DM, van Honk J, Vergouwen AC, Koerselman GF. Partial clinical response to 2 weeks of 2 Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression. Int J Neuropsychopharmacol. 2009;12:643–50.PubMedCrossRef Schutter DJ, Laman DM, van Honk J, Vergouwen AC, Koerselman GF. Partial clinical response to 2 weeks of 2 Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression. Int J Neuropsychopharmacol. 2009;12:643–50.PubMedCrossRef
76.
Zurück zum Zitat Höppner J, Schulz M, Irmisch G, Mau R, Schläfke D, Richter J. Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci. 2003;253:103–9.PubMed Höppner J, Schulz M, Irmisch G, Mau R, Schläfke D, Richter J. Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci. 2003;253:103–9.PubMed
77.
Zurück zum Zitat Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10:1116–24.PubMedCrossRef Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10:1116–24.PubMedCrossRef
Metadaten
Titel
Effect of repetitive transcranial magnetic stimulation on rectal function and emotion in humans
verfasst von
Yuuichi Aizawa
Joe Morishita
Michiko Kano
Takayuki Mori
Shin-Ichi Izumi
Kenichiro Tsutsui
Toshio Iijima
Motoyori Kanazawa
Shin Fukudo
Publikationsdatum
01.09.2011
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 9/2011
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-011-0423-9

Weitere Artikel der Ausgabe 9/2011

Journal of Gastroenterology 9/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.